Tomas Björklund

3.4k total citations · 1 hit paper
53 papers, 2.5k citations indexed

About

Tomas Björklund is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Tomas Björklund has authored 53 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 24 papers in Cellular and Molecular Neuroscience and 18 papers in Genetics. Recurrent topics in Tomas Björklund's work include Virus-based gene therapy research (17 papers), CRISPR and Genetic Engineering (16 papers) and Parkinson's Disease Mechanisms and Treatments (12 papers). Tomas Björklund is often cited by papers focused on Virus-based gene therapy research (17 papers), CRISPR and Genetic Engineering (16 papers) and Parkinson's Disease Mechanisms and Treatments (12 papers). Tomas Björklund collaborates with scholars based in Sweden, United States and France. Tomas Björklund's co-authors include Deniz Kirik, Patrick Aldrin-Kirk, Jiayi Li, Staffan Holmqvist, Cecilia Lundberg, Wen Li, Ronald Melki, Laurent Roybon, Luc Bousset and Zhan‐You Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuron and Journal of Neuroscience.

In The Last Decade

Tomas Björklund

53 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats

2014 689 citations Staffan Holmqvist, Patrick Aldrin-Kirk et al. profile →

Peers

Tomas Björklund

NEURO

CMN

GENET

PHYSI

Ross Bland New Zealand

Fritz Zimprich Austria

Helen L. Fitzsimons New Zealand

Masaharu Hayashi Japan

Christel Depienne France

Eulàlia Martı́ Spain

Ruth Chia United States

Bryan B. Yoo United States

Jodi L. McBride United States

Carlos Barcia Spain

Ross Bland New Zealand

Tomas Björklund

1.4k ×1.2

431 ×0.4

NEURO

1.1k ×1.3

CMN

588 ×1.5

GENET

406 ×1.3

PHYSI

Citations per year, relative to Tomas Björklund Tomas Björklund (= 1×) peers Ross Bland

Countries citing papers authored by Tomas Björklund

Since Specialization

Citations

This map shows the geographic impact of Tomas Björklund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Björklund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Björklund more than expected).

Fields of papers citing papers by Tomas Björklund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas Björklund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Björklund. The network helps show where Tomas Björklund may publish in the future.

Co-authorship network of co-authors of Tomas Björklund

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Björklund. A scholar is included among the top collaborators of Tomas Björklund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Björklund. Tomas Björklund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morel, Gustavo R., et al.. (2025). GDNF overexpression in astrocytes enhances branching and partially preserves hippocampal function in an Alzheimer’s rat model. Scientific Reports. 15(1). 19284–19284. 1 indexed citations

Storm, Petter, Yu Zhang, Fredrik Nilsson, et al.. (2024). Lineage tracing of stem cell–derived dopamine grafts in a Parkinson’s model reveals shared origin of all graft-derived cells. Science Advances. 10(42). eadn3057–eadn3057. 1 indexed citations

Björklund, Tomas, et al.. (2024). Preventive cognitive protection based on AAV9 overexpression of IGF1 in hippocampal astrocytes. Neurobiology of Disease. 200. 106612–106612. 1 indexed citations

Davidsson, Marcus, Patrick Aldrin-Kirk, Tiago Cardoso, et al.. (2023). Deconvolution of spatial sequencing provides accurate characterization of hESC-derived DA transplants in vivo. Molecular Therapy — Methods & Clinical Development. 29. 381–394. 4 indexed citations

Aldrin-Kirk, Patrick, Malin Åkerblom, Tiago Cardoso, et al.. (2021). A novel two-factor monosynaptic TRIO tracing method for assessment of circuit integration of hESC-derived dopamine transplants. Stem Cell Reports. 17(1). 159–172. 7 indexed citations

Björklund, Tomas & Marcus Davidsson. (2021). Next-Generation Gene Therapy for Parkinson’s Disease Using Engineered Viral Vectors. Journal of Parkinson s Disease. 11(s2). S209–S217. 10 indexed citations

Davidsson, Marcus, Gang Wang, Patrick Aldrin-Kirk, et al.. (2019). A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism. Proceedings of the National Academy of Sciences. 116(52). 27053–27062. 106 indexed citations

Aldrin-Kirk, Patrick & Tomas Björklund. (2019). Practical Considerations for the Use of DREADD and Other Chemogenetic Receptors to Regulate Neuronal Activity in the Mammalian Brain. Methods in molecular biology. 1937. 59–87. 13 indexed citations

Davidsson, Marcus, Oliver Daniel Schwich, Patrick Aldrin-Kirk, et al.. (2018). Molecular barcoding of viral vectors enables mapping and optimization of mRNAtrans-splicing. RNA. 24(5). 673–687. 6 indexed citations

10.

Björklund, Tomas. (2018). Repairing the Brain: Gene Therapy. Journal of Parkinson s Disease. 8(s1). S123–S130. 4 indexed citations

11.

Aldrin-Kirk, Patrick, Andreas Heuer, Daniella Rylander Ottosson, et al.. (2017). Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum. Neurobiology of Disease. 109(Pt A). 148–162. 33 indexed citations

12.

Aldrin-Kirk, Patrick, Marcus Davidsson, Staffan Holmqvist, Jiayi Li, & Tomas Björklund. (2014). Novel AAV-Based Rat Model of Forebrain Synucleinopathy Shows Extensive Pathologies and Progressive Loss of Cholinergic Interneurons. PLoS ONE. 9(7). e100869–e100869. 27 indexed citations

13.

Şahin, Gürdal, et al.. (2012). Design of a Single AAV Vector for Coexpression of TH and GCH1 to Establish Continuous DOPA Synthesis in a Rat Model of Parkinson's Disease. Molecular Therapy. 20(7). 1315–1326. 27 indexed citations

14.

Ulusoy, Ayşe, Tomas Björklund, Kerstin Buck, & Deniz Kirik. (2012). Dysregulated dopamine storage increases the vulnerability to α-synuclein in nigral neurons. Neurobiology of Disease. 47(3). 367–377. 48 indexed citations

15.

Soylu-Kucharz, Rana, Tomas Björklund, Bengt‐Frederik Belgardt, et al.. (2011). Mutant Huntingtin Causes Metabolic Imbalance by Disruption of Hypothalamic Neurocircuits. Cell Metabolism. 13(4). 428–439. 88 indexed citations

16.

Iwamoto, Mari, Tomas Björklund, Cecilia Lundberg, Deniz Kirik, & Thomas J. Wandless. (2010). A General Chemical Method to Regulate Protein Stability in the Mammalian Central Nervous System. Chemistry & Biology. 17(9). 981–988. 276 indexed citations

17.

Björklund, Tomas & Deniz Kirik. (2009). Scientific rationale for the development of gene therapy strategies for Parkinson's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1792(7). 703–713. 32 indexed citations

18.

Ulusoy, Ayşe, Gürdal Şahin, Tomas Björklund, Patrick Aebischer, & Deniz Kirik. (2009). Dose Optimization for Long-term rAAV-mediated RNA Interference in the Nigrostriatal Projection Neurons. Molecular Therapy. 17(9). 1574–1584. 56 indexed citations

19.

Ulusoy, Ayşe, Tomas Björklund, Stephan Hermening, & Deniz Kirik. (2007). In vivo gene delivery for development of mammalian models for Parkinson's disease. Experimental Neurology. 209(1). 89–100. 33 indexed citations

20.

Carlsson, Thomas, Tomas Björklund, & Deniz Kirik. (2007). Restoration of the Striatal Dopamine Synthesis for Parkinsons Disease:Viral Vector-Mediated Enzyme Replacement Strategy. Current Gene Therapy. 7(2). 109–120. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact